Question 1

What is Iovance Biotherapeutics?

Accepted Answer

Iovance Biotherapeutics is a biopharmaceutical company pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient.

Question 2

What is Tumor Infiltrating Lymphocyte (TIL) Therapy?

Accepted Answer

Tumor Infiltrating Lymphocytes (TILs) are naturally occurring immune cells that fight cancer. Investigational TIL therapies are designed to reinvigorate a patient's TILs to fight cancer. A patient's naturally occurring TILs are collected and grown outside the body so they can be administered back to the patient as a one-time treatment.

Question 3

What is Peripheral Blood Lymphocyte (PBL) Therapy?

Accepted Answer

Iovance is also investigating peripheral blood lymphocyte (PBL) therapy, which utilizes the patient's own immune cells from the peripheral blood to fight cancer.

Question 4

What clinical trials does Iovance have ongoing?

Accepted Answer

Iovance has several clinical trials ongoing to evaluate its investigational TIL and PBL therapies for various cancer types. Patients can view information about Iovance's clinical trials on the company's website.

Question 5

What is Iovance's manufacturing process?

Accepted Answer

Iovance has developed the Iovance Cell Therapy Center to manufacture its investigational TIL and PBL therapies. The company's proprietary manufacturing process is designed to efficiently scale the production of these patient-specific cell therapies.

Iov

Company Overview

Company Name

Address

Website

Phone

Approx. Annual Revenue

Established

About Iov

Frequently Asked Questions about Iov

What is Iovance Biotherapeutics?

What is Tumor Infiltrating Lymphocyte (TIL) Therapy?

What is Peripheral Blood Lymphocyte (PBL) Therapy?

What clinical trials does Iovance have ongoing?

What is Iovance's manufacturing process?

Technologies Used

Social Profiles

Key Decision Makers